Mo Chen
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms
Papers in
- Hematology 25
- Hematopoietic Stem Cell Transplantation 15
- Platelet Disorders and Treatments 7
-
- RNA Research and Splicing 9
- Bone Metabolism and Diseases 6
- Extracellular vesicles in disease 6
- Co-authors
- James L. Manley (6 shared papers)Charles J. David (8 shared papers)Peter Canoll (1 shared paper)Marcela C. Assanah (1 shared paper)Regis J. O’Keefe (8 shared papers)Di Chen (6 shared papers)T.M. Penning (10 shared papers)Joan Massagué (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Cell Reports (3 papers)Chemico-Biological Interactions (3 papers)Nature Communications (3 papers)The FASEB Journal (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Mo Chen
176 papers receiving 8.2k citations
Mo Chen's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 912
- Rheumatology 812
- Molecular Biology 3.6k
- Genetics 252
- Oncology 645
Countries citing papers authored by Mo Chen
This map shows the geographic impact of Mo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Chen more than expected).
Fields of papers citing papers by Mo Chen
This network shows the impact of papers produced by Mo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Chen. The network helps show where Mo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches Hit paper breakdown → | 2009 | 985 |
| 2 | HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer Hit paper breakdown → | 2009 | 975 |
| 3 | TGF-β Tumor Suppression through a Lethal EMT Hit paper breakdown → | 2016 | 512 |
| 4 | 2008 | 416 | |
| 5 | 2010 | 188 | |
| 6 | 2005 | 140 | |
| 7 | 2015 | 140 | |
| 8 | 2019 | 138 | |
| 9 | 2007 | 122 | |
| 10 | 2008 | 122 | |
| 11 | 2017 | 119 | |
| 12 | 2022 | 114 | |
| 13 | 2009 | 104 | |
| 14 | 2018 | 103 | |
| 15 | 2012 | 102 | |
| 16 | 2012 | 95 | |
| 17 | 2021 | 92 | |
| 18 | 2020 | 87 | |
| 19 | 2008 | 86 | |
| 20 | 2019 | 85 |
About Mo Chen
Mo Chen is a scholar working on Hematology, Molecular Biology, Oncology, Rheumatology and Cell Biology, having authored 180 papers that have together received 8.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (15 papers), Aldose Reductase and Taurine (10 papers), Osteoarthritis Treatment and Mechanisms (10 papers), RNA Research and Splicing (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Platelet Disorders and Treatments (7 papers), Bone Metabolism and Diseases (6 papers) and Extracellular vesicles in disease (6 papers). The work is most often cited by research in Cancer Research (912 citations), Rheumatology (812 citations), Molecular Biology (3.6k citations), Genetics (252 citations) and Oncology (645 citations). Mo Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include James L. Manley, Charles J. David, Peter Canoll, Marcela C. Assanah, Regis J. O’Keefe, Di Chen, T.M. Penning, Joan Massagué, Christine A. Iacobuzio–Donahue and Yilong Zou. Their work appears in journals such as Journal of Biological Chemistry, Cell Reports, Chemico-Biological Interactions, Nature Communications and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.